Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05883163Not ApplicableRecruiting

STIMIT Activator 1 IDE Study

Role: lead

NCT05238753Not ApplicableTerminated

Electromagnetic Stimulation of the Phrenic Nerve in Critically Ill Mechanically Ventilated Patients (STIMIT-II)

Role: collaborator

NCT05107167Not ApplicableCompleted

Electromagnetic Stimulation of the Phrenic Nerve of Intubated Patients With Obesity

Role: collaborator

NCT04884698Not ApplicableCompleted

"Electromagnetical Stimulation of Phrenic Nerve to Generate Contraction of the Diaphragm"

Role: lead

NCT04946110Not ApplicableCompleted

Electromagnetic Stimulation of the Phrenic Nerve of Intubated Patients

Role: collaborator

All 5 trials loaded